| Ytd | 3.77% | |
| 1y | -20.29% |
| Open | 1.61 | Prev Close | 1.62 | Low | 1.59 | High | 1.73 | Mkt Cap | 163.65M |
| Vol | 1.61M | Avg Vol | 2.04M | EPS | -1.19 | P/E | -1.39 | Forward P/E | -0.90 |
| Beta | 2.36 | Short Ratio | 4.55 | Inst. Own | 62.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.89 | 200-d Avg | 1.92 | 1yr Est | 12.50 |
CRBU News
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients
Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceu
HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a B
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.26) per share which beat the anal
HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a
Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmace
Evercore ISI Group analyst Jonathan Miller maintains Caribou Biosciences (NASDAQ:CRBU) with a Out
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.28) per share which beat the anal
Clear Street analyst Bill Maughan initiates coverage on Caribou Biosciences (NASDAQ:CRBU) with a
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
During Monday's trading, 1214 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.